September 16, 2009
Gilead Sciences to Present at the UBS Global Life Sciences Conference on Monday, September 21
Webcast Available Through Gilead Corporate Website
FOSTER CITY, Calif.--(BUSINESS WIRE)--Sep. 16, 2009--
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate
presentation will be webcast from the UBS Global Life Sciences
Conference in New York.
Kevin Young, Gilead’s Executive Vice President, Commercial Operations,
along with Robin Washington, Senior Vice President and Chief Financial
Officer, will provide an overview of the company at the UBS conference
on Monday, September 21 at 9:30 a.m. Eastern Daylight Time.
To access the live webcast or a replay via the internet log on to www.gilead.com.
Please connect to the company’s website at least 15 minutes prior to the
start of the presentation to ensure adequate time for any software
download that may be necessary to listen to the webcast. The replay will
be available for 14 days following the presentation.
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company’s mission is to advance the care of patients suffering
from life-threatening diseases worldwide. Headquartered in Foster City,
California, Gilead has operations in North America, Europe and Australia.
For more information on Gilead Sciences, please visit www.gilead.com
call the Gilead Public Affairs Department at
Source: Gilead Sciences, Inc.
Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936